The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Share
More article options
Full text access
Does immunosuppressive induction with anti-thymocyte globulin offer any advantage over anti-IL-2R monoclonal antibodies in patients with deaddonor renal transplant and high risk for delayed graft function or acute rejection?
¿Ofrece ventajas la inducción inmunosupresora con globulina antitimocítica frente a los anticuerpos monoclonales anti IL-2R en pacientes con trasplante renal de cadáver que tienen un alto riesgo de función retrasada del injerto o rechazo agudo?
Visits
3414
J. J. Amenábar Iríbar, F. J. García López
This item has received
Article information




